user-group INVESTOR ACCESS
Search
Close this search box.
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. Amyl Therapeutics receives additional...

News / Venture Capital

Amyl Therapeutics receives additional €5M funding to advance therapeutic platform

8 November 2023
Investor base strengthened by Mr Evren Ucok joining as new shareholder and continued support from historical investors Financing will be used to accelerate development of Amyl technology platform to treat neurodegenerative diseases and AL amyloidosis

Download

Press Release
Download

Related News

  • Venture Capital
  • Other news

Private Corner lance un feeder sur le thème de la santé avec Mérieux Equity Partners, pour son fonds Mérieux Innovation 2

arrow-up-right
  • Venture Capital
  • Other news

The Mérieux Innovation 2 fund is awarded the Tibi label, in recognition of its support to healthcare innovation in France and Europe, for the benefit of patients.

arrow-up-right
  • Buyout
  • Other news

Integrating Nature: at the heart of our “One Health” approach.

arrow-up-right
Lyon
Paris
Contact
  • ⓒ MERIEUX EQUITY PARTNERS 2023
  • Mérieux Equity Partners vehicles are only open to Professional Clients - as defined in the French Monetary code (CMF) and AMF regulation (RG).